These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 31534329)

  • 21. pH-Responsive Nanoparticles for Enhanced Antitumor Activity by High-Intensity Focused Ultrasound Therapy Combined with Sonodynamic Therapy.
    Gao H; Wang Z; Tan M; Liu W; Zhang L; Huang J; Cao Y; Li P; Wang Z; Wen J; Shang T; Ran H
    Int J Nanomedicine; 2022; 17():333-350. PubMed ID: 35115772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
    Fu D; Huang X; Lv Z; Zhang Y; Chen M; Zhang W; Su D
    Bioengineered; 2022 Mar; 13(3):7105-7117. PubMed ID: 35259049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing multifunctional cancer-targeted nanosystem for magnetic resonance molecular imaging-guided theranostics of lung cancer.
    Gao P; Mei C; He L; Xiao Z; Chan L; Zhang D; Shi C; Chen T; Luo L
    Drug Deliv; 2018 Nov; 25(1):1811-1825. PubMed ID: 30465437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model.
    Zhang Y; Yong L; Luo Y; Ding X; Xu D; Gao X; Yan S; Wang Q; Luo J; Pu D; Zou J
    Sci Rep; 2019 May; 9(1):6982. PubMed ID: 31061456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Destruction Of Laser-Induced Phase-Transition Nanoparticles Triggered By Low-Intensity Ultrasound: An Innovative Modality To Enhance The Immunological Treatment Of Ovarian Cancer Cells.
    Xie W; Zhu S; Yang B; Chen C; Chen S; Liu Y; Nie X; Hao L; Wang Z; Sun J; Chang S
    Int J Nanomedicine; 2019; 14():9377-9393. PubMed ID: 31819438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
    Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T
    Gao L; Yu J; Liu Y; Zhou J; Sun L; Wang J; Zhu J; Peng H; Lu W; Yu L; Yan Z; Wang Y
    Theranostics; 2018; 8(1):92-108. PubMed ID: 29290795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoenzyme-Augmented Cancer Sonodynamic Therapy by Catalytic Tumor Oxygenation.
    Zhu P; Chen Y; Shi J
    ACS Nano; 2018 Apr; 12(4):3780-3795. PubMed ID: 29613770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI tracing non-invasive TiO
    Yuan P; Song D
    Nanotechnology; 2018 Mar; 29(12):125101. PubMed ID: 29350186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
    Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
    Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted Fe-doped silica nanoparticles as a novel ultrasound-magnetic resonance dual-mode imaging contrast agent for HER2-positive breast cancer.
    Li X; Xia S; Zhou W; Ji R; Zhan W
    Int J Nanomedicine; 2019; 14():2397-2413. PubMed ID: 31040664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy.
    Guo F; Fu Q; Zhou K; Jin C; Wu W; Ji X; Yan Q; Yang Q; Wu D; Li A; Yang G
    J Nanobiotechnology; 2020 Mar; 18(1):48. PubMed ID: 32183823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
    Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
    Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanin-loaded biocompatible photosensitive nanoparticles for controlled drug release in combined photothermal-chemotherapy guided by photoacoustic/ultrasound dual-modality imaging.
    Wang W; Jing T; Xia X; Tang L; Huang Z; Liu F; Wang Z; Ran H; Li M; Xia J
    Biomater Sci; 2019 Oct; 7(10):4060-4074. PubMed ID: 31475710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mitochondria-targeted anticancer nanoplatform with deep penetration for enhanced synergistic sonodynamic and starvation therapy.
    Zhang R; Zhang L; Ran H; Li P; Huang J; Tan M; Yang Y; Wang Z
    Biomater Sci; 2020 Aug; 8(16):4581-4594. PubMed ID: 32691765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ conversion of rose bengal microbubbles into nanoparticles for ultrasound imaging guided sonodynamic therapy with enhanced antitumor efficacy.
    Hou R; Liang X; Li X; Zhang X; Ma X; Wang F
    Biomater Sci; 2020 May; 8(9):2526-2536. PubMed ID: 32215400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional theranostic contrast agent for photoacoustics- and ultrasound-based tumor diagnosis and ultrasound-stimulated local tumor therapy.
    Moon H; Kang J; Sim C; Kim J; Lee H; Chang JH; Kim H
    J Control Release; 2015 Nov; 218():63-71. PubMed ID: 26432554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.